Article
Dermatology
Janan Mohamad, Liat Samuelov, Natalia Malchin, Tom Rabinowitz, Sari Assaf, Liron Malki, Kiril Malovitski, Shirli Israeli, Meital Grafi-Cohen, Ora Bitterman-Deutsch, Vered Molho-Pessach, Eran Cohen-Barak, Gideon Bach, Ben Zion Garty, Reuven Bergman, Avikam Harel, Arti Nanda, Giles G. Lestringant, John McGrath, Stavit Shalev, Noam Shomron, Jacob Mashiah, Marina Eskin-Schwartz, Eli Sprecher, Ofer Sarig
Summary: Autosomal recessive congenital ichthyosis (ARCI) is a rare skin disorder characterized by pathogenic variants in multiple ARCI-associated genes. Our study in Middle Eastern population revealed a higher prevalence of CYP4F22 and ABCA12 pathogenic variants, and lower prevalence of TGM1 and NIPAL4 variants.
EXPERIMENTAL DERMATOLOGY
(2021)
Review
Pharmacology & Pharmacy
Sheila I. Pena-Corona, Stephany Celeste Gutierrez-Ruiz, Ma de los Dolores Campos Echeverria, Hernan Cortes, Manuel Gonzalez-Del Carmen, Gerardo Leyva-Gomez
Summary: Autosomal recessive congenital ichthyoses (ARCI) is a genetic skin disorder that significantly affects patients' quality of life. Although there are existing treatments, the search for new therapeutic strategies, particularly drug repurposing, is necessary.
FRONTIERS IN PHARMACOLOGY
(2023)
Article
Veterinary Sciences
Ana Petak, Ivan-Conrado Sostaric-Zuckermann, Marko Hohsteter, Niksa Lemo
Summary: This study aimed to investigate the clinical and histological effects of isotretinoin on golden retriever dogs with autosomal recessive congenital ichthyosis (ARCI) associated with mutations in the PNPLA1 gene. The results showed that oral isotretinoin treatment was effective in improving ichthyosis without any side-effects.
VETERINARY SCIENCES
(2022)
Article
Biochemistry & Molecular Biology
Daria S. Chulpanova, Alisa A. Shaimardanova, Aleksei S. Ponomarev, Somaia Elsheikh, Albert A. Rizvanov, Valeriya V. Solovyeva
Summary: Autosomal recessive congenital ichthyosis (ARCI) is caused by mutations in genes responsible for lipid barrier formation and functioning. Current treatments for ARCI focus on symptomatic relief. Gene and cell therapies show promise in correcting protein activity but are still at an early stage of development.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Dermatology
John C. Freedman, Trevor J. Parry, Peipei Zhang, Avijit Majumdar, Suma Krishnan, Lauren K. Regula, Mark O'Malley, Sarah Coghlan, S. D. Yogesha, Sureshkumar Ramasamy, Pooja Agarwal
Summary: The study found that KB105 gene therapy vector could deliver functional human TGM1 to keratinocytes, restoring enzyme function. Animal studies demonstrated that KB105 could induce TGM1 protein expression in the target epidermal layer without triggering fibrosis, necrosis, or acute inflammation. Toxicity and biodistribution assessments showed that KB105 was well-tolerated and restricted to the dose site.
JOURNAL OF INVESTIGATIVE DERMATOLOGY
(2021)
Article
Dermatology
Minu Jose Chiramel, Lydia Mathew, Rekha Athirayath, Aaron Chapla, Dharshini Sathishkumar, Thenmozhi Mani, Sumita Danda, Renu George
Summary: A hospital in Mumbai conducted a study on the genotype of autosomal recessive congenital ichthyosis among patients from the Indian subcontinent, and found pathogenic and likely pathogenic variants in 22 out of 28 patients.
PEDIATRIC DERMATOLOGY
(2022)
Article
Dermatology
Lina Zhao, Caixia Wang, Yaning Zhang, Jinyun Li, Huize Liu, Dairong Feng
Summary: This study identified compound heterozygous mutations in the CYP4F22 gene as the cause of congenital ichthyosis in a Chinese neonatal boy. The mutations were classified as pathogenic based on in silico analyses and in vitro functional studies, which also showed that the mutant protein levels could be restored by trichostatin A (TSA) treatment.
JOURNAL OF DERMATOLOGY
(2022)
Review
Dermatology
E. Cuperus, A. Bygum, L. Boeckmann, C. Bodemer, M. C. Bolling, M. Caproni, A. Diociaiuti, S. Emmert, J. Fischer, A. Gostynski, S. Guez, M. E. van Gijn, K. Hannulla-Jouppi, C. Has, A. Hernandez-Martin, A. E. Martinez, J. Mazereeuw-Hautier, M. Medvecz, I. Neri, V. Sigurdsson, K. Suessmuth, H. Traupe, V. Oji, S. G. M. A. Pasmans
Summary: The broad differential diagnosis of neonatal erythroderma is a diagnostic challenge. Early recognition of the underlying cause is crucial for better treatment and prognosis. Based on the study of 74 cases, a 6-step diagnostic flowchart for neonatal erythroderma is proposed.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
(2022)
Article
Genetics & Heredity
Fatima Alabdulrazzaq, Talal Alanzi, Haya H. H. Al-Balool, Alice Gardham, Emma Wakeling, Harry G. G. Leitch, Moeenaldeen AlSayed, Maha Abdulrahim, Abdulaziz Aladwani, Antonio Romito, Kapil Kampe, Sacha Ferdinandusse, Ashraf H. H. Aboelanine, Amira Abdullah, Amal Alwadani, Laila Bastaki, Frederic M. Vaz, Aida M. M. Bertoli-Avella, Dana Marafi
Summary: VLCFAs are essential for the synthesis of cell membranes in the brain, skin, and retina. Variants in the ELOVL4 gene are associated with Mendelian disorders such as macular dystrophy, spinocerebellar ataxia, and congenital ichthyosis. The study identified three novel homozygous ELOVL4 variants, including a tribal founder mutation in two unrelated Saudi families.
MOLECULAR GENETICS & GENOMIC MEDICINE
(2023)
Article
Medicine, General & Internal
Minna Kraatari-Tiri, Maria K. Haanpaa, Tytti Willberg, Pia Pohjola, Riikka Keski-Filppula, Outi Kuismin, Jukka S. Moilanen, Sanna Hakli, Elisa Rahikkala
Summary: Sensorineural hearing loss (SNHL) is a common sensory deficit worldwide, and genetic factors contribute significantly to congenital hearing loss. This study identified TMC1 gene variants associated with different types of hearing loss. Early diagnosis and timely hearing rehabilitation can lead to good speech perception in noise for affected individuals.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Dermatology
Anissa Zaouak, Amal Chamli, Nadia Ben Mansour, Wafa Jouini, Samy Fenniche, Houda Hammami
Summary: This study aimed to describe the nail changes in autosomal recessive congenital ichthyosis (ARCI). A total of 25 ARCI patients were included in the study, and various nail abnormalities were observed, including periungual hyperkeratosis, xanthonychia, and pachyonychia. The results showed a significantly higher frequency of nail changes in adults compared to children.
CLINICS IN DERMATOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Takuya Takeichi, Yusuke Ohno, Kana Tanahashi, Yasutoshi Ito, Ken Shiraishi, Ryo Utsunomiya, Satoshi Yoshida, Kenta Ikeda, Hayato Nomura, Shin Morizane, Koji Sayama, Tomoo Ogi, Yoshinao Muro, Akio Kihara, Masashi Akiyama
Summary: Self-healing collodion baby (SHCB) is a rare and mild variant of autosomal recessive congenital ichthyosis. Genetic testing and ceramide analysis can help with the early and accurate diagnosis of congenital ichthyoses, including SHCB.
JOURNAL OF LIPID RESEARCH
(2022)
Article
Genetics & Heredity
Damiano Abeni, Roberta Rotunno, Andrea Diociaiuti, Simona Giancristoforo, Domenico Bonamonte, Carmelo Schepis, Iria Neri, Daniele Castiglia, Giovanna Zambruno, May El Hachem
Summary: ARCI imposes a major socio-economic and psychological burden on family caregivers, with time needed for care, extra-housework, and household expenditure being the most affected dimensions. Disease severity is significantly correlated with higher family burden, and features such as recurrent infections, foul-smell, palmoplantar keratoderma, scales on the face, and ear deformities contribute to greater family burden.
ORPHANET JOURNAL OF RARE DISEASES
(2021)
Article
Genetics & Heredity
Salam Massadeh, Maha Albeladi, Nour Albesher, Fahad Alhabshan, Kapil Dev Kampe, Farah Chaikhouni, Mohamed S. Kabbani, Christian Beetz, Manal Alaamery
Summary: This study identified a novel PRKD1 variant in a consanguineous Saudi family with three daughters affected by Congenital Heart Defects (CHDs) using whole exome sequencing (WES). The homozygous variant found in the affected daughters was also present in their asymptomatic father, suggesting a possible autosomal recessive inheritance pattern with gender limitation. This finding sheds new light on the genotype-phenotype association between PRKD1 and CHDs, providing insight into the genetic determinants of CHDs.
Editorial Material
Medicine, General & Internal
Sultan Al-Khenaizan, Luluah Al-Mubarak
Summary: A 2-month-old baby boy presented with generalized erythroderma since birth, with a positive family history. The patient appeared ill with diffuse scalp scaling, but no signs of ectropion, eclabium, or deformed ears were observed. Hair microscopy showed findings as in Figure 2, and all laboratory results were normal.
SAUDI MEDICAL JOURNAL
(2021)
Article
Allergy
Maria Suprun, Robert Getts, Galina Grishina, Angela Tsuang, Mayte Suarez-Farinas, Hugh A. Sampson
Article
Allergy
Benjamin Ungar, Ana B. Pavel, Randall Li, Grace Kimmel, John Nia, Peter Hashim, Hee Jin Kim, Margot Chima, Anjali S. Vekaria, Yeriel Estrada, Hui Xu, Xiangyu Peng, Giselle K. Singer, Danielle Baum, Yasaman Mansouri, Mark Taliercio, Emma Guttman-Yassky
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
(2021)
Article
Allergy
Axel P. Villani, Ana B. Pavel, Jianni Wu, Marie Fernandes, Catherine Maari, Etienne Saint-Cyr Proulx, Carolyn Jack, Jacob Glickman, Seulah Choi, Helen He, Benjamin Ungar, Yeriel Estrada, Naoya Kameyama, Ning Zhang, Juana Gonzales, Jean-Claude Tardif, James G. Krueger, Robert Bissonnette, Emma Guttman-Yassky
Summary: The study found significant correlations between vascular inflammation and Th2-related products in the skin and blood of AD patients, as well as atherosclerosis-related markers modulated by dupilumab. Circulating levels of endothelial microparticles were significantly higher in severe AD patients and tended to correlate with vascular inflammation.
Article
Dermatology
Daniela Mikhaylov, Ester Del Duca, Caroline Meyer Olesen, Helen He, Jianni Wu, Benjamin Ungar, Yeriel Estrada, Ning Zhang, Mashkura Chowdhury, Maja-Lisa Clausen, James G. Krueger, Ana B. Pavel, Tove Agner, Emma Guttman-Yassky
Summary: This study utilized tape-strips to obtain skin tissue from AD patients before and after dupilumab treatment for analysis of gene expression changes and therapeutic response biomarkers. Results showed significant modulation in key AD immune and barrier biomarkers with dupilumab treatment, which were correlated with clinical disease improvements.
Article
Allergy
Benjamin Ungar, Jacob W. Glickman, Alexandra K. Golant, Celina Dubin, Olga Marushchak, Alyssa Gontzes, Daniela Mikhaylov, Giselle K. Singer, Danielle Baum, Nancy Wei, Antonio Sanin, Diana Gruenstein, Mark G. Lebwohl, Ana B. Pavel, Emma Guttman-Yassky
Summary: This study aimed to investigate the hypothesis that targeting Th2 with the IL4Ra-antagonist, dupilumab, could rebalance the Th1/Th2 axis in inflammatory disease patients, potentially leading to attenuated COVID-19 symptoms.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
(2022)
Editorial Material
Biochemistry & Molecular Biology
Thomas U. Marron, Matthew D. Galsky, Bachir Taouli, Maria Isabel Fiel, Stephen Ward, Edward Kim, David Yankelevitz, Deborah Doroshow, Emma Guttman, Benjamin Ungar, Saurabh Mehandru, Benjamin J. Golas, Daniel Labow, John Sfakianos, Sujit S. Nair, Dimple Chakravarty, Michael Buckstein, Xiaoyu Song, Effi Kenigsberg, Sacha Gnjatic, Brian D. Brown, Joseph Sparano, Ashutosh Tewari, Myron Schwartz, Nina Bhardwaj, Miriam Merad
Summary: Window-of-opportunity trials offer a platform to understand the mechanisms of short-duration pre-surgical therapies, but there is a need for a paradigm shift in trial design, specimen collection, and analysis.
Article
Oncology
Jean-Eudes Fahrner, Imran Lahmar, Anne-Gaelle Goubet, Yacine Haddad, Agathe Carrier, Marine Mazzenga, Damien Drubay, Carolina Alves Costa Silva, Eric de Sousa, Cassandra Thelemaque, Clea Melenotte, Agathe Dubuisson, Arthur Geraud, Gladys Ferrere, Roxanne Birebent, Camille Bigenwald, Marion Picard, Luigi Cerbone, Joana R. Lerias, Ariane Laparra, Alice Bernard-Tessier, Benoit Kloeckner, Marianne Gazzano, Francois-Xavier Danlos, Safae Terrisse, Eugenie Pizzato, Caroline Flament, Pierre Ly, Eric Tartour, Nadine Benhamouda, Lydia Meziani, Abdelhakim Ahmed-Belkacem, Makoto Miyara, Guy Gorochov, Fabrice Barlesi, Alexandre Trubert, Benjamin Ungar, Yeriel Estrada, Caroline Pradon, Emmanuelle Gallois, Fanny Pommeret, Emeline Colomba, Pernelle Lavaud, Marc Deloger, Nathalie Droin, Eric Deutsch, Bertrand Gachot, Jean-Philippe Spano, Mansouria Merad, Florian Scotte, Aurelien Marabelle, Frank Griscelli, Jean-Yves Blay, Jean-Charles Soria, Miriam Merad, Fabrice Andre, Juliette Villemonteix, Mathieu F. Chevalier, Sophie Caillat-Zucman, Florence Fenollar, Emma Guttman-Yassky, Odile Launay, Guido Kroemer, Bernard La Scola, Markus Maeurer, Lisa Derosa, Laurence Zitvogel
Summary: This study investigates the polarity and specificity of memory T cells against SARS-CoV-2 viral lysates and peptides to determine factors associated with protection against COVID-19. The research reveals a potential imbalance in cytokine release and a specific T cell deficit that may contribute to susceptibility to COVID-19. Current vaccines show variable efficacy in triggering immune responses, suggesting the need for next-generation vaccines to address viral variants.
Review
Pharmacology & Pharmacy
Julia Cheng, Paola Facheris, Benjamin Ungar, Emma Guttman-Yassky
Summary: Chronic hand eczema (CHE) is a burdensome condition with limited treatment options. This review discusses the pathogenesis and currently available treatments for CHE, as well as emerging drugs being studied in clinical trials. Expert opinion suggests that immunomodulatory drugs such as JAK inhibitors and Th2-targeting antibodies hold promise for CHE treatment. Future management of CHE may involve more targeted therapies through clinical trials, moving away from broad immunosuppressants with more side effects.
EXPERT OPINION ON INVESTIGATIONAL DRUGS
(2022)
Article
Allergy
Angel D. Pagan, Eden David, Benjamin Ungar, Sabrina Ghalili, Helen He, Emma Guttman-Yassky
Summary: This study reviewed the long-term treatment responses and adverse events of children and adolescents with atopic dermatitis (AD) treated with dupilumab. The results showed that dupilumab was effective and well-tolerated in treating pediatric and adolescent AD patients.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
(2022)
Article
Allergy
Ana B. Pavel, Ester Del Duca, Julia Cheng, Jianni Wu, Benjamin Ungar, Yeriel D. Estrada, Carolyn Jack, Catherine Maari, Etienne Saint-Cyr Proulx, Francisco Ramirez-Valle, James G. Krueger, Robert Bissonnette, Emma Guttman-Yassky
Summary: The treatment of inflammatory skin diseases needs experimental models of skin inflammation in humans to predict treatment effects. In this study, four common sensitizers were administered to healthy patients, and it was found that diphencyprone induced the strongest immune response and best modeled the barrier defects characteristic of atopic dermatitis and psoriasis.
Letter
Allergy
Benjamin Ungar, Susan Hartzell, Daniel Lozano-Ojalvo, Sabrina Ghalili, Swaroop Bose, Alexandra K. Golant, Kathryn Tan, Yeriel D. Estrada, Giselle K. Singer, Ana B. Pavel, Paolo Cravedi, Emma Guttman-Yassky
Letter
Dermatology
Shayan Owji, Helen He, Joseph Han, Peter Baek, Daniel Yassky, Nicholas Gulati, Benjamin Ungar, Jonathan Ungar
INTERNATIONAL JOURNAL OF DERMATOLOGY
(2023)
Review
Allergy
Shayan Owji, Stella A. Caldas, Benjamin Ungar
Summary: The ruxolitinib cream showed high efficacy and favorable safety profile in treating atopic dermatitis patients.
JOURNAL OF ASTHMA AND ALLERGY
(2022)
Letter
Dermatology
Ross O'Hagan, Stella A. Caldas, Joel Correa M. da Rosa, Emma Guttman-Yassky, Benjamin Ungar
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
(2023)
Letter
Allergy
Benjamin Ungar, Leore Lavin, Alexandra K. Golant, Alyssa Gontzes, Eden David, Yeriel D. Estrada, Giselle K. Singer, Ana B. Pavel, Emma Guttman-Yassky
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
(2022)